Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.
about
Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosisThe multifarious, multireplicon Burkholderia cepacia complexFirst time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case reportCharacterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. novDiversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia.Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria.Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.The changing microbial epidemiology in cystic fibrosis.Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates.Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCRTaxonomy and identification of the Burkholderia cepacia complexPCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.Culture-based and non-growth-dependent detection of the Burkholderia cepacia complex in soil environments.Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosisLow rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, CanadaPractical management of cystic fibrosis.Cystic fibrosis: a polymicrobial infectious disease.Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis.Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities.Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients.Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis.Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex.Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.
P2860
Q24550797-F953B50C-8007-4D9B-A54D-620C7B7F4E8CQ28301994-F2A718FA-B856-453B-8961-4C6F3E664B3CQ28817223-59FCD16B-F0FE-4421-860F-AD42E3F86844Q30695296-2E704292-8BBC-4D3F-AAAD-88D4BCBCD8C7Q33323078-C9E36C6C-6AD1-4126-818E-7A0121D5A788Q33327477-26B942EE-9702-49A7-A5C4-7AC2A86E4F17Q33358120-F065CBF3-6C61-4F81-AFAF-90C69A6C1B8EQ33358344-83DEF23C-CB02-4C5C-B421-6A38DDA90BE2Q33681762-F61F1F66-602C-482D-8BE5-B4EAED6679FEQ33825634-47E41222-1E76-4C7D-B459-4BEBD28BEF22Q33852394-1DA34137-FC91-4DEC-9D6B-4EED1BD0E4A0Q33878547-17A85032-9849-4C25-A05F-79B0C375B599Q33970448-CD0F3EB9-87A9-4706-9702-DCE04D37BF86Q33973532-7513CD6D-9390-48EE-B198-D0AF3CC8383EQ33974179-6E150DCE-8655-4015-B49E-2B5A3BBE85EBQ34057557-6757E33F-3968-4F6D-AED4-BCF60F6EFF3DQ34073326-518BA1B7-7660-4AE0-BFC5-3687BEAACBC5Q34330072-18F05CDF-63BC-4030-A26E-DDBECC398FABQ34568983-734D9000-C49D-4325-BF7F-FA087831D504Q34956792-D30C4031-9B23-44CE-9D4E-649A9952400EQ35213050-DE69C1DC-6265-415A-9B48-4E05624318D5Q36014916-1BD57EB4-A8A1-4D65-9135-8B493DF661E7Q36568679-B18FD26C-0758-4152-9249-FD4218C07AF5Q36895733-D1FD5FCD-8054-465B-8935-508B93DD07A9Q37994908-D1F1B832-9749-43EF-84A6-5470B63FD05EQ38476154-15BDDA4B-843F-4C1C-ADCF-D7181F27BE37Q38863609-F88659F3-B91F-43A3-AA37-5AD0A45C926EQ39225829-D73CC98C-F9D3-4346-A509-8B4AD76F17EBQ39460330-2CFC6044-37CF-4DE4-98F3-0B1BBD7930FBQ39463759-8FF1D678-52B4-43F6-BDF0-EB1ECCAA3FF0Q39467342-C93FD8DD-7D67-425E-9E14-7FEE5731FB12Q39665032-C12490F3-CCC4-42C4-97FD-C4CD55FC772BQ39665321-0F43B5CB-F3A6-4BB3-A863-1EF7A13D7345Q39697563-90D0B345-893E-4C2F-8172-452612D682DDQ39732748-63FE0FEC-3A1B-4A02-A7B2-8C277F3935EFQ40179086-32978E29-0337-4042-9A74-DD7D514EAEA5Q41819863-248C1C89-B884-4726-8D5B-9768CE6D3EE5Q42083986-C05D30C0-3DB5-469A-8C8B-3B3D4437A5FAQ42286592-DD76E900-1964-43F0-8DCF-876135FCBA01Q42537143-9C8D519D-86E8-4748-99ED-CD5F985A69C8
P2860
Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@en
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@nl
type
label
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@en
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@nl
prefLabel
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@en
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@nl
P2093
P356
P1433
P1476
Misidentification of Burkholde ...... 1,051 recent sputum isolates.
@en
P2093
J D McMenamin
J J LiPuma
P Vandamme
T M Zaccone
P304
P356
10.1378/CHEST.117.6.1661
P407
P50
P577
2000-06-01T00:00:00Z